Sign in

CIK 0001158780

  • Non-accelerated filer
  • Smaller reporting company
Ticker
PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
NV
Entity type
Operating
EIN
980351734
Phone
+972 747107171
Business address
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
Former names
PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
  1. 4 Grant or award Director acquired 133,000 shares (grant or award)
  2. 4 Grant or award Director acquired 90,000 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 150,000 shares (grant or award)
  4. 4 Grant or award Co-CEO & President acquired 2,000,000 shares (grant or award)
  5. 4 Grant or award Co-CEO & Chairman acquired 2,000,000 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Grant or award CEO & Chairman acquired 200,000 shares (grant or award)
  8. 4 Grant or award CFO, COO & President acquired 200,000 shares (grant or award)
  9. 4 Grant or award Director acquired 66,500 shares (grant or award)
  10. 4 Grant or award Director acquired 45,000 shares (grant or award)
  11. 4 Grant or award Director acquired 65,500 shares (grant or award)
  12. 4 Grant or award Director acquired 45,000 shares (grant or award)
  13. 4 Grant or award Director acquired 66,500 shares (grant or award)
  14. 4 Grant or award Director acquired 45,000 shares (grant or award)
  15. 4 Grant or award Director acquired 66,500 shares (grant or award)
  16. 4 Open-market sale Director sold 12,346 shares at $1.52 ($18,784)
  17. 4 Open-market buy CEO & Chairman bought 5,000 shares at $1.33 ($6,650)
  18. 4 Open-market buy CFO, COO & President bought 5,000 shares at $1.20 ($6,000)
  19. 4 Open-market buy CEO & Chairman bought 15,000 shares at an average $1.07 ($15,990)
  20. 4 Open-market buy CFO, COO & President bought 15,000 shares at an average $0.95 ($14,250)

Page 6 of 18 · 352 filings